Thermo Fisher's (TMO) Autoimmune Disease Test Gets FDA Nod

Thermo Fisher Scientific, Inc. TMO announced the receipt of the FDA clearance for EliA RNA Polymerase III and EliA Rib-P blood tests intended to diagnose systemic sclerosis (SSc) and systemic lupus erythematosus (SLE). With the addition of these tests, the EliA portfolio will deliver a more robust clinical offering through a wide-ranging menu of automated connective tissue disease tests.